- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Molycorp Fails to Find Buyer, Fate of Mountain Pass Still Unknown
The Wall Street Journal reported that Molycorp (OTCMKTS:MCPIQ) has failed to garner any acceptable offers for its business, but Bondholders are crying foul, stating the company should not have rejected their bid.
The Wall Street Journal reported that Molycorp (OTCMKTS:MCPIQ) has failed to garner any acceptable offers for its business, but Bondholders are crying foul, stating the company should not have rejected their bid.
As quoted in the publication:
After scrapping an auction because of a lack of acceptable bids, Molycorp is trying to get out of bankruptcy reorganized around one line of business, Neo, with the fate of another still up in the air. Mountain Pass, a facility in California that is the only U.S. source of rare-earths elements used in consumer electronics, went unsold and may be liquidated.
Bondholders are saying Molycorp wrongly rejected their bid for the Mountain Pass facility—the only bid that came in for a line of business Molycorp spent $1.7 billion to establish.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â